Evidence map›Paper›PMID 38426199›Full record

ArticleJournal of clinical and translational hepatology2024

Impact of Onset Time, Number, Type, and Sequence of Extrahepatic Organ Failure on Prognosis of Acute-on-chronic Liver Failure.

Shaotian Qiu, Qian Zhang, Jiaxuan Hu, Lewei Wang, Rui Chen, Yingying Cao, Fang Liu, Zhenjun Yu, Caiyan Zhao, Liaoyun Zhang and 5 more

Abstract read
In one paragraph

Article in Journal of clinical and translational hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. [Guidelines for the diagnosis and treatment of acute-on-chronic liver failure (2025 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Guideline
  2. [Guidelines for diagnosis and treatment of liver failure (2024 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Guideline
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shaotian QiuThe School of Medicine, Nankai University, Tianjin, China.
Qian ZhangDepartment of Gastroenterology and Hepatology, Tianjin Union Medical Center, Tianjin, China.
Jiaxuan HuThe School of Medicine, Nankai University, Tianjin, China.
Lewei WangDepartment of Gastroenterology and Hepatology, Tianjin Union Medical Center of Tianjin Medical University, Tianjin, China.
Rui ChenDepartment of Gastroenterology and Hepatology, Tianjin Union Medical Center of Tianjin Medical University, Tianjin, China.
Yingying CaoDepartment of Hepatology and Gastroenterology, The Third Central Clinical College of Tianjin Medical University, Tianjin, China.
Fang LiuDepartment of Hepatology and Gastroenterology, The Third Central Clinical College of Tianjin Medical University, Tianjin, China.
Zhenjun YuDepartment of Gastroenterology and Hepatology, Tianjin Union Medical Center, Tianjin, China.
Caiyan ZhaoDepartment of Infectious Disease, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Liaoyun ZhangDepartment of Infection Disease, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Wanhua RenInfectious Department of Shandong First Medical University Affiliated Shandong Provincial Hospital, Jinan, Shandong, China.
Shaojie XinLiver Failure Treatment and Research Center, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Yu ChenLiver Disease Center (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, China.
Zhongping DuanLiver Disease Center (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, China.
Tao HanThe School of Medicine, Nankai University, Tianjin, China.ORCID https://orcid.org/0000-0003-4216-6968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: The impact of the characteristics of extrahepatic organ failure (EHOF) including the onset time, number, type, and sequence on the prognosis of acute-on-chronic liver failure (ACLF) patients remains unknown. This study aimed to identify the association between the characteristics of EHOF and the prognosis of ACLF patients. Methods: ACLF subjects enrolled at six hospitals in China were included in the analysis. The risk of mortality based on the characteristics of EHOF was evaluated. Survival of study groups was compared by Kaplan-Meier analysis and log-rank tests. Results: A total of 736 patients with ACLF were included. EHOF was observed in 402 patients (54.6%), of which 295 (73.4%) developed single EHOF (SEHOF) and 107 (26.6%) developed multiple EHOF (MEHOF). The most commonly observed EHOF was coagulation failure (47.0%), followed by renal (13.0%), brain (4.9%), respiratory (4.3%), and circulatory (2.3%) failure. Survival analysis found that MEHOF or SEHOF patients with brain failure had a worse prognosis. However, no significant outcome was found in the analysis of the effect of onset time and sequence of failed organs on prognosis. Patients were further divided into three risk subgroups by the EHOF characteristics. Kaplan-Meier analysis showed that risk stratification resulted in the differentiation of patients with different risks of mortality both in the training and validation cohorts. Conclusions: The mortality of ACLF patients was determined by the number and type, but not the onset time and sequence of EHOF. Risk stratification applicable to clinical practice was established.

Indexed as

Acute-on-chronic liver failureBrain failureExtrahepatic organ failurePrognosis

Identifiers

PMID38426199
PMCPMC10899869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.